Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,900
Employees9,900
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1954
Founded1954
Employees
9,900
Employees9,900

ELAN Key Statistics

Market cap
10.33B
Market cap10.33B
Price-Earnings ratio
-42.63
Price-Earnings ratio-42.63
Dividend yield
Dividend yield
Average volume
8.40M
Average volume8.40M
High today
$21.33
High today$21.33
Low today
$20.07
Low today$20.07
Open price
$20.51
Open price$20.51
Volume
2.33M
Volume2.33M
52 Week high
$27.72
52 Week high$27.72
52 Week low
$12.40
52 Week low$12.40

Stock Snapshot

The current Elanco(ELAN) stock price is $20.68, with a market capitalization of 10.33B. The stock trades at a price-to-earnings (P/E) ratio of -42.63.

On 2026-05-21, Elanco(ELAN) stock moved within a range of $20.07 to $21.33. With shares now at $20.68, the stock is trading +3.0% above its intraday low and -3.0% below the session's peak.

Trading volume for Elanco(ELAN) stock has reached 2.33M, versus its average volume of 8.4M.

The stock's 52-week range extends from a low of $12.40 to a high of $27.72.

The stock's 52-week range extends from a low of $12.40 to a high of $27.72.

ELAN News

Simply Wall St 2d
Is It Too Early To Give Up On Elanco Animal Health After Recent Share Price Weakness?

Considering whether Elanco Animal Health at around US$19.80 is still offering value, or if the easy gains are already behind it. The stock is down 7.6% over th...

Is It Too Early To Give Up On Elanco Animal Health After Recent Share Price Weakness?
TipRanks 2d
Top Elanco Executives Quietly Boost Their Stakes in a Big Way

New insider activity at Elanco Animal Health ( (ELAN) ) has taken place on May 19, 2026. Unlock hedge fund-level data and powerful investing tools for smarter,...

TipRanks 3d
Elanco launches Befrena for canine allergic itch

Elanco (ELAN) announced the phased launch of Befrena – tirnovetmab -, a new anti-IL-31 monoclonal antibody injection for treatment of canine allergic and atopic...

Analyst ratings

94%

of 17 ratings
Buy
94.1%
Hold
5.9%
Sell
0%

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.